A human monoclonal antibody blocking SARS-CoV-2 infection

  • Unique Paper ID: 149461
  • Volume: 6
  • Issue: 12
  • PageNo: 396-401
  • Abstract:
  • The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV). This cross-neutralizing antibody targets a communal epitope on these viruses and offers potential for prevention and treatment of COVID-19.

Copyright & License

Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{149461,
        author = {Rutuja Survase and Anjum Saudagar and Runali bharti and Renuka R. Deshpande},
        title = {A human monoclonal antibody blocking SARS-CoV-2 infection},
        journal = {International Journal of Innovative Research in Technology},
        year = {},
        volume = {6},
        number = {12},
        pages = {396-401},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=149461},
        abstract = {The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV). This cross-neutralizing antibody targets a communal epitope on these viruses and offers potential for prevention and treatment of COVID-19.},
        keywords = {COVID-19 , monoclonal antibody},
        month = {},
        }

Cite This Article

  • ISSN: 2349-6002
  • Volume: 6
  • Issue: 12
  • PageNo: 396-401

A human monoclonal antibody blocking SARS-CoV-2 infection

Related Articles